Peter Ruminski, M.S.
Center for World Health and Medicine
Translate basic research discoveries and developed leads into viable drug candidates for neglected diseases of the poor, orphan diseases and other unmet medical needs.
Office: DRC, Room 313
Phone: (314) 977-5126
M.S., Washington University in St. Louis
Current goal is to lead the Center's talented and highly skilled pharmaceutical scientists to translate basic research discoveries and developed leads into viable drug candidates for neglected diseases of the poor, orphan diseases and other unmet medical needs. Some of these current targets include anti-secretory agents for the treatment of childhood diarrhea, malaria and other parasitic diseases, sickle cell disease, pulmonary fibrosis, retinopathies and TB.
- Pharmacologic comparison of clinical neutral endopeptidase inhibitors in a rat model of acute secretory diarrhea.
Griggs DW, Prinsen MJ, et al. J Pharmacol Exp Ther. (2015) Feb 23 [Epub ahead of print].
- Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.
Meyers MJ, Anderson EJ, et al. Bioorg Med Chem. (2015) 23(16):5144-5150.